Monoclonal Antibodies in the Treatment of Hematologic Malignancies: Radiation Dosimetry Aspects

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|2|4|351-356

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.2, Iss.4, 2001-01, pp. : 351-356

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The History and Rationale for Monoclonal Antibodies in the Treatment of Hematologic Malignancy

By  

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 4, 2001-12 ,pp. : 293-300

Bentham Science Publishers

Access to resources Recommend Favorite

Infectious Complications Associated With Immunomodulating Monoclonal Antibodies Used in the Treatment of Hematologic Malignancy

By Koo Sophia   Baden Lindsey R.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 2, 2008-02 ,pp. : 202-213

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Immunotoxins in the Treatment of Hematologic Malignancies

By  

Current Drug Targets, Vol. 7, Iss. 10, 2006-01 ,pp. : 1301-1311

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Concepts for the Treatment of Hematological Malignancies with Therapeutic Monoclonal Antibodies

By  

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 790-800

Bentham Science Publishers

Access to resources Recommend Favorite

Entinostat for treatment of solid tumors and hematologic malignancies

By Knipstein Jeffrey   Gore Lia  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1455-1467

Informa Healthcare

Access to resources Recommend Favorite